Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer

Hsulf-1 is a newly identified enzyme, which has the ability to decrease the growth of hepatocellular, ovarian, and head and neck squamous cell carcinoma cells by interfering with heparin-binding growth factor signaling. Since pancreatic cancers over-express a number of heparin-binding growth factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Junsheng, Kleeff, Jörg, Abiatari, Ivane, Kayed, Hany, Giese, Nathalia A, Felix, Klaus, Giese, Thomas, Büchler, Markus W, Friess, Helmut
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087876/
https://www.ncbi.nlm.nih.gov/pubmed/15817123
http://dx.doi.org/10.1186/1476-4598-4-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087876/
https://www.ncbi.nlm.nih.gov/pubmed/15817123
http://dx.doi.org/10.1186/1476-4598-4-14

Ejemplares similares